Microsaic Systems Plc (LON:MSYS) CEO Glenn Tracey talks to DirectorsTalk about its unaudited interim results for the six months ended 30 June 2018. With a 96% increase in revenues and good operation progress Glenn provides us with a little more detail around the results, explains the changes he has made since being appointed as CEO 1 year ago, updates us on the move into life sciences and lets us know what to expect over the remainder of 2018.
Microsaic Systems plc (LON:MSYS) has announced the addition of a new technology capability to its platform, as part of the strategic transition from equipment only sales to remote detection and analysis of human diagnostics and environmental health
Microsaic Systems plc (LON:MSYS) has announced the immediate roll-out of its compact Mass Spectrometry technology integrated with autosampler and separation technology, wrapped in closed-loop (automated) control software, for use in the scale-up and operation of drug
Microsaic Systems plc (LON:MSYS), has noted the update by DeepVerge plc (LON:DVRG) provided today regarding their orders for pathogen monitoring equipment for shipment this year to partners and customers in UK, India and China, which includes upgrades to DeepVerge Modern
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments and analytical solutions, has announced its unaudited interim results for the six months ended 30 June 2021. A strategic change of business model early
Microsaic Systems’ Glenn Tracey discusses the highlights from their final results, what the 12 OEM & distribution agreements mean to the business operationally, the benefits of the MiD ProteinID products and how the new financial year has started in this exclusive interview with DirectorsTalk.
Microsaic Systems plc (LON:MSYS) CEO Glenn Tracey joins DirectorsTalk to discuss full year results. Glenn talks us through the highlights, with 12 OEM and distribution agreements in place what this means for the business, the benefits the
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, today announced its audited financial results for the year ended 31 December 2019. The Company’s Annual Report is included at the end
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, has today announced the appointment of WH Ireland Limited as Joint Broker with immediate effect, alongside N+1Singer as Nominated Adviser and Joint Broker.
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, today announced that it has signed a global integration and joint sales and marketing heads of terms with Axcend Corp to integrate the
Microsaic Systems (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, has today confirmed that revenues for the year ending 31 December 2019 have significantly exceeded 2018, and increasing momentum is being achieved in
Microsaic Systems (LON:MSYS), the developer of point-of-need mass spectrometry instruments, has today announced that it has partnered with the Centre for Process Innovation, utilising the CPI’s UK biotherapeutics facility, to demonstrate the potential use of Microsaic’s
Microsaic Systems (LON:MSYS), the developer of point of need mass spectrometry instruments, has announced that it has signed an exclusive distribution agreement with ST Japan Inc to distribute Microsaic’s branded 4500 MiD® MS detector in Japan.
Microsaic Systems PLC (LON:MSYS), the developer of point of need mass spectrometry instruments, has today announced that it has signed a distribution agreement with CM Corporation Ltd for the exclusive distribution of the Microsaic 4500 MiD®
Microsaic Systems plc (LON: MSYS), the developer of point of need mass spectrometry instruments, has developed proof of concept workflows to analyse in real-time complex samples from bioreactors, which could enable customers to achieve significant costs
Microsaic Systems plc (LON: MSYS) will hold its AGM today, at 11 a.m., at the offices of N+1 Singer Advisory LLP, One Bartholomew Lane, London, EC2N 2AX. Ahead of that meeting, the Company provides an update
Microsaic Systems plc (LON: MSYS), the developer of point of need mass spectrometry (“MS”) instruments, announces that its Chinese partner, Unimicro Technologies Inc. (“Unimicro”), has completed further integrations of Microsaic’s technology with Unimicro’s separation technology. Glenn
Microsaic Systems plc (LON: MSYS), the developer of point of need mass spectrometry instruments, has today announced that its Annual General Meeting will be held at 11.00 a.m. on 14 May 2019 at the offices of N+1
Glenn Tracey, CEO of Microsaic, commented, “I am very pleased to partner with BMT to integrate Microsaic’s compact, point of need MS technology, with their HPLC products. The team at BMT has the in-depth technical expertise
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.